SCHEMBL5815510

SCHEMBL5815510

O=C([N]C(=O)C1CCCCC1)C1CCCCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.55
CES1 P23141 1/20 0.55
HDAC8 Q9BY41 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
TSHR P16473 3/20 0.44
ALDH1A1 P00352 2/20 0.44
HSD11B1 P28845 3/20 0.39
EPHX1 P07099 6/20 0.38
RECQL P46063 1/20 0.38
HSD11B2 P80365 1/20 0.37
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPT P10636 1/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP3A4 P08684 1/20 0.36
EPHX2 P34913 1/20 0.36
MGLL Q99685 1/20 0.36
MAPK1 P28482 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1170172 0.84 CES2 (0.33) CES2CES1MAPTLMNA
SCHEMBL19971755 0.82 CES2 (0.55) CES2CES1HDAC8HDAC6TSHR
SCHEMBL19393778 0.80 CES2 (0.52) CES2CES1HDAC8HDAC6TSHR
SCHEMBL9298492 0.80 CES2 (0.52) CES2CES1HDAC8HDAC6TSHR
SCHEMBL13273624 0.80 CES2 (0.52) CES2CES1HDAC8HDAC6TSHR
SCHEMBL1678567 0.78 CES2 (0.50) CES2CES1HDAC8HDAC6TSHR
SCHEMBL22419009 0.78 CES2 (0.50) CES2CES1HDAC8HDAC6TSHR
SCHEMBL1596590 0.78 CES2 (0.50) CES2CES1HDAC8HDAC6TSHR
SCHEMBL1679605 0.78 CES2 (0.50) CES2CES1HDAC8HDAC6TSHR
SCHEMBL9199647 0.76 CES2 (0.48) CES2CES1HDAC8HDAC6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO disclosed